Evolent Health, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Evolent Health, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2014 to Q2 2024.
  • Evolent Health, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 115M shares, a 3.06% increase year-over-year.
  • Evolent Health, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 111M shares, a 18.7% increase from 2022.
  • Evolent Health, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 93.7M shares, a 8.87% increase from 2021.
  • Evolent Health, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 86.1M shares, a 1.34% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 115M +3.41M +3.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 114M +6.36M +5.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 111M +17.6M +18.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 112M +17M +17.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 111M +21.2M +23.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 108M +18.3M +20.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 93.7M +7.63M +8.87% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 95.3M +9.49M +11.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 90.1M +4.62M +5.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 89.5M +4.84M +5.72% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 86.1M +1.14M +1.34% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 85.8M +628K +0.74% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 85.4M +99K +0.12% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 84.7M -123K -0.15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 84.9M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 85.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 85.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 84.8M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2018 78M +7.67M +10.9% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 77.2M +17.7M +29.8% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 75.4M +22.8M +43.3% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q4 2017 64.4M +19.3M +42.9% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-01
Q3 2017 70.3M +27.2M +63.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 59.5M +16.9M +39.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 52.6M +10.4M +24.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 45M +19.9M +79.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 43.1M +1.64M +3.96% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 42.6M +28.6M +205% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 42.2M +39.2M +1312% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 25.1M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 41.5M +39M +1555% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 14M +11.7M +515% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 2.99M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q3 2014 2.51M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 2.27M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.